Education
About Us
Working with TipRanks
Follow Us
Cell Source Inc (CLCS)
OTHER OTC:CLCS
CLCS Stock Chart & Stats
$0.90
>-$0.01(-0.30%)
At close: 4:00 PM EST
$0.90
>-$0.01(-0.30%)
Day’s Range― - ―
52-Week Range$0.18 - $0.99
Previous CloseN/A
Volume3.40K
Average Volume (3M)4.44K
Market Cap
$39.12M
Enterprise Value$50.53M
Total Cash (Recent Filing)$74.63K
Total Debt (Recent Filing)$10.07M
Price to Earnings (P/E)―
Beta-264.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding43,468,185
10 Day Avg. Volume11,735
30 Day Avg. Volume4,444
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)-0.78
Price to Sales (P/S)0.00
P/FCF Ratio-5.46
Enterprise Value/Market Cap1.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-14.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cell Source News
CLCS FAQ
What was Cell Source Inc’s price range in the past 12 months?
Cell Source Inc lowest stock price was $0.18 and its highest was $0.99 in the past 12 months.
What is Cell Source Inc’s market cap?
Cell Source Inc’s market cap is $39.12M.
When is Cell Source Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cell Source Inc’s earnings last quarter?
Currently, no data Available
Is Cell Source Inc overvalued?
According to Wall Street analysts Cell Source Inc’s price is currently Overvalued.
Does Cell Source Inc pay dividends?
Cell Source Inc does not currently pay dividends.
What is Cell Source Inc’s EPS estimate?
Cell Source Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cell Source Inc have?
Cell Source Inc has 43,468,185 shares outstanding.
What happened to Cell Source Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cell Source Inc?
Currently, no hedge funds are holding shares in CLCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cell Source Inc
Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. Cell Source, Inc. was founded in 2012 and is headquartered in New York, New York.